NYSE
MPT
Last Price
US $3.5
KEY FIGURES
MKT CAP
$2.1B
EPS
TTM$-0.05
EPS Growth (1Y)
-88.56%
PEG
TTMN/M
P/E
TTMN/M
P/S
TTM2.05x
YIELD
10.3%
GROWTH (5Y CAGR)
Revenue
-4.89%
EBITDA
Valuation
Financial
Performance
Cash flow to debt coverage
Medical Properties Trust, Inc. cash flow to debt ratio of 2.35% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
Medical Properties Trust, Inc.'s free cash flow has decreased 5.99% from $245.48M last year to $230.77M, signaling decreasing performance
Debt-to-equity ratio
Medical Properties Trust, Inc.'s debt to equity ratio is 2.16, which means that the company's assets are unhealthy financed, signaling financial risk.
Debt-to-equity trend
Medical Properties Trust, Inc.'s debt has increased relative to shareholder equity from 1.86 last year to 2.16 today, signaling weakened financials
Net debt to EBITDA
Medical Properties Trust, Inc. has a net debt to EBITDA ratio of 17.01x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Interest coverage
Medical Properties Trust, Inc.'s interest coverage ratio is 0.89, which means that the company struggles to meet interest obligations, signaling financial risk.
Profit margin growth
Medical Properties Trust, Inc.'s profit margin was -242.11% last year and is -2.96% this year, signaling increasing performance
Current ratio
Medical Properties Trust, Inc.'s short-term assets of $1.82B exceed its short-term liabilities of $1.21B
Return on assets
Medical Properties Trust, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Medical Properties Trust, Inc.'s return on equity of -0.66%, is lower than 15.00%, indicating bad performance
Earnings quality
Medical Properties Trust, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Medical Properties Trust, Inc. has insufficient public price history to evaluate earnings stability.
Positive free cash flow
Medical Properties Trust, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Free cash flow yield
Medical Properties Trust, Inc. has a free cash flow yield of 10.81%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Earnings growth
Medical Properties Trust, Inc.'s yearly earnings has increased 88.51% since last year from $-2.41B to $-277.05M, signaling increasing performance
Revenue growth
Medical Properties Trust, Inc.'s yearly revenue has decreased 2.36% since last year from $995.55M to $972.02M, signaling decreasing performance
Return on invested capital
ROIC 3.75% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Medical Properties Trust, Inc.'s 3-year revenue CAGR of -14.27% is negative, indicating declining revenue over the past 3 years
Revenue consistency
Medical Properties Trust, Inc. has insufficient public price history to evaluate revenue consistency.
Return on equity consistency
Medical Properties Trust, Inc. has insufficient public price history to evaluate ROE consistency.
Base Cash Flow Valuation (DCF)
Medical Properties Trust, Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
Medical Properties Trust, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Base EBITDA Valuation
Medical Properties Trust, Inc. is overvalued relative to its fair value price of 0.00 based on Base EBITDA Valuation model
EV/EBITDA (FY)
Medical Properties Trust, Inc. has an EV/EBITDA ratio of 20.92x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
PEG ratio (TTM/FY)
Medical Properties Trust, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
Medical Properties Trust, Inc. has a price-to-book ratio of 0.47x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
Medical Properties Trust, Inc. has a price-to-sales ratio of 2.09x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-0.66%
Return on equity
ROIC: 3.75%
Valuation History
-
Price to Earnings
EV/EBITDA: 10.8X
Cash flow
Profit margin
-13.15%
Cash flow
-
Fair Value
Market $3.5
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.